Family Medicine Doctors in Lafayette, GA Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Dr. Fred Joseph Duhon, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1110 N Main St, Lafayette, GA 30728 Phone: 706-638-2002 Fax: 706-638-2014 |
Mr. Max Russell Baldwin Jr., PAC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 E. Villanow St., Lafayette, GA 30728 Phone: 706-638-1606 Fax: 706-638-9987 |
Thomas L Garcia, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 East Villanow Street, Lafayette, GA 30728 Phone: 706-638-1606 Fax: 706-638-9987 |
News Archive
HIV-I damages the immune system early than originally thought
New research into the earliest events occurring immediately upon infection with HIV-I shows that the virus deals a stunning blow to the immune system earlier than was previously understood. According to scientists at Duke University Medical Center, this suggests the window of opportunity for successful intervention may be only a matter of days - not weeks - after transmission, as researchers had previously believed.
Roundup: Mass. launches information exchange; Ga. fight brews over new prompt-pay rule
Massachusetts on Tuesday launched a statewide health information exchange that will allow health care providers to share electronic health information as they seek to improve coordination of care, lower costs and increase patient safety. Gov. Deval Patrick successfully sent his health data from 907-bed Massachusetts General Hospital in Boston to 659-bed Baystate Medical Center in Springfield as part of the launch.
Study reveals potential therapeutic target to tackle ADHD and impulsivity
A study published in the journal Pharmacological Research describes the existence of a complex built by dopamine and noradrenergic receptors that could be a therapeutic target of potential interest to tackle the attention deficit hyperactivity disorder (ADHD) and impulsivity.
Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML
Celator Pharmaceuticals, Inc. today announced that the Phase 3 clinical trial of VYXEOS (cytarabine:daunorubicin) Liposome for Injection (also known as CPX-351) in patients with untreated high-risk (secondary) acute myeloid leukemia (AML) has reached its pre-specified number of events required for the analysis of overall survival.
PreCision Dermatology formed as a result of spin-out of Onset Therapeutics
PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.
› Verified 4 days ago